Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2022

Jan 26, 2022

32853_dirs_2022-01-25_346373cd-f096-4c8b-9ef3-982d073baa7c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2022-01-23

Reporting Person: McCracken Colin (Chief Commercial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-01-23 Restricted Stock Units $ A 50000 Acquired Common Stock (50000.0) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."